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Abstract
Background: We investigated the underlying molecular mechanisms of bone overgrowth after femoral fracture by
using high-throughput bioinformatics approaches.
Methods: The gene expression profile of GSE3298 (accession number) was obtained from the Gene Expression
Omnibus database. Sixteen femoral growth plate samples, including nine samples without fracture and seven
fracture samples for seven time points, were used for analysis. The Limma package was applied to identify
differentially expressed genes (DEGs) between fractured and intact samples. The DAVID online tool was used for
Gene ontology functional and pathway enrichment analysis. A protein-protein interaction (PPI) network established
by String software was used to identify interactions between significant DEGs, and network modules were detected
using plug-in MCODE. Additionally, a transcription regulatory network was constructed based on the ENCODE
Project and PPI network.
Results: A total of 680 DEGs were screened in fractured femoral growth plate samples compared with controls,
including 238 up- and 442 down-regulated genes. These DEGs were significantly involved in the calcium signaling
pathway and cancer pathway. A PPI network was constructed with 167 nodes and 233 edges, and module analysis
demonstrated that CCL2, CSF2, NOS2, and DLC1 may stimulate bone overgrowth after femoral fracture via anti-
apoptosis-related functions. A transcription regulatory network was constructed with 387 interacting pairs, and
overlapping nodes were significantly enriched in intracellular signaling cascade and regulation of cell proliferation,
among others.
Conclusions: Bone overgrowth was associated with changes in the expression of identified DEGs such as CCL2,
NOS2, CSF2, and DLC1 in the femoral head. They may be important in regulating bone overgrowth via the anti-
apoptosis of osteoblasts.
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Background
Femoral fracture, which is one of the most commonly
occurring fractures during childhood, always results
from casual falls, motor vehicle accidents, or sporting
accidents [1]. Treatment of femoral fracture typically in-
cludes open-reduction, traction, and internal fixation.
However, pediatric femoral fracture often results in the
stimulation of bone overgrowth, particularly in children
younger than 12 years [2, 3]. Overgrowth is described as
a universal phenomenon in patients with femoral shaft
fractures and can elongate the lower limb by nearly
9 mm [4] or 11 mm [5]. It is crucial to explore the
underlying molecular mechanism of bone overgrowth
associated with femoral fracture.
In recent years, numerous studies have investigated
the molecular mechanism of bone overgrowth after fem-
oral fracture [6–8]. Bone homeostasis is thought to be
maintained by a balance between bone formation by os-
teoblasts and bone resorption by osteoclasts in the
growth plate. Various proteins such as β-catenin and
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triggering receptor expressed by myeloid cells-2 interact
with each other by controlling the rate of osteoclasto-
genesis and further regulating bone homeostasis [9].
Several other factors were also found to be involved in
this process. For instance, lipoprotein receptor-related
protein 4 (LRP4) was found to be associated with the in-
hibitory function of sclerostin which is secreted by oste-
ocytes and inhibits bone formation [6]. Additionally, the
Wnt1/β-catenin signaling pathway is crucial for embry-
onic and bone homeostasis [10–12], and LRP4 may in-
crease sclerostin secretion through Wnt1/β-catenin
signaling [7]. Moreover, fibroblast growth factor receptor
(FGFR) is also a critical gene in bone overgrowth and
participates in FGFR3 signaling, further affecting chon-
drocyte proliferation [8]. Another report showed that
osteocrin is highly expressed in osteoblasts and interacts
with C-type natriuretic peptide receptors to modulate
the action of the natriuretic system during bone elong-
ation [13]. Therefore, expression changes of such related
genes in cells after femoral fracture may provide insight
into the physiological mechanisms of bone overgrowth.
In the past few years, DNA microarray technology has
been increasingly utilized to comprehensively test for
changes in the messenger RNA (mRNA) expression of
genes and search for evidence of overgrowth after mid-
femoral fracture [3, 14]. However, the potential molecu-
lar mechanism of bone overgrowth after mid-shaft
femur fracture also remains unclear. The aim of this
study was to explore potentially important genes associ-
ated with bone overgrowth after femoral fracture and




The gene expression profile of GSE3298 [3, 14], which
describes mRNA expression in the rat proximal femoral
growth plate after mid-shaft fracture, was derived from
the Gene Expression Omnibus (GEO, http://ncbi.nlm.
nih.gov/geo/) database based on the GPL1355 Affy
metrix Rat Genome 230 2.0 Array platform (Santa Clara,
CA, USA). A total of 16 femoral growth plate samples
were used for analysis, including nine samples without
fracture and seven fracture samples for seven time
points: 1 day, 3 days, 1 week, 2 weeks, 3 weeks, 4 weeks,
and 6 weeks, after mid-shaft fracture.
Data preprocessing and differentially expressed genes
(DEGs) screening
Each sample in the obtained dataset had a probe ID,
which was converted into the corresponding gene name.
Multiple probe IDs targeting the same gene were averaged
as the gene expression value. After expression values were
log2 transformed, quantile normalization was carried out
[15]. The Limma package (http://www.bioconductor.org/
packages/release/bioc/html/limma.html) [16] in R lan-
guage was used to screen DEGs between intact and frac-
tured samples. Gene expression differences were assessed
using Student’s t test, and expression changes were con-
sidered to be significant when by P < 0.05.
Functional annotation and pathway enrichment of DEGs
Functional annotation of genes was carried out using the
Database for Annotation, Visualization, and Integrated
Discovery (DAVID, http://david.abcc.ncifcrf.gov/) [17].
Gene ontology (GO, http://geneontology.org/) annota-
tion and pathway enrichment analysis were performed
to derive all associated functions with their enrichment
scores and P values. Fisher’s exact test was used to
evaluate the differences between the intact and fractured
femora. Only results showing enrichment scores of more
than 2 and P values <0.05 were considered to be statisti-
cally significant.
Construction of protein-protein interaction (PPI) network
The PPI is thought to be important for understanding
the potential functions of a certain protein. The up- and
down-regulated genes identified as described above were
respectively mapped to the Search Tool for the Retrieval
of Interacting Genes (STRING, http://string-db.org/)
software which is commonly used to predict PPI pairs
[18]. The PPI network was constructed with interest-
ing PPI pairs and visualized by Cytoscape 2.8 (http://
cytoscape.org/) [19].
Module detection
Molecular complex detection (MCODE) [20] is a clus-
tering algorithm used to identify molecular complexes in
the PPI network. Degree ≥2 and k-score ≥2 were se-
lected as cutoff criteria. Next, Bingo [21] was applied to
perform GO functional enrichment analysis with a
threshold of adjusted P value <0.05, with multiple test
adjustment conducted as described by Benjamini-
Hochberg.
Transcription regulatory network
The ENCODE (ENCyclopedia of DNA Elements) Pro-
ject is designed to identify all functional components
in the human genome sequence, including protein-
coding genes, non-protein-coding genes, sequences
that mediate chromosome structure and dynamics,
and transcriptional regulatory elements [22]. Based on
transcription factor information determined using EN-
CODE and the PPI network, a transcription regula-
tory network was constructed with interacting pairs
using Cytoscape. Additionally, overlapping nodes in
the network with node degrees of >2 were further an-
alyzed for functional enrichment using DAVID. Only
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After data preprocessing and quantile normalization, the
gene expression profile of GSE3298 was used to screen
for DEGs in the proximal femoral growth plate between
intact and fractured samples. A total of 680 DEGs were
screened out with P < 0.05, including 238 up- and 442
down-regulated genes (Additional file 1: Table S1).
Functional analysis and pathway enrichment for DEGs
To evaluate DEG functions, GO and pathway analysis
were performed for up-regulated and down-regulated
genes, respectively. As shown in Table 1, up-regulated
genes were mainly enriched in seven GO terms includ-
ing cell fraction, response to organic substance, and
response to wounding, among others, while down-
regulated genes mainly function in the extracellular
region, vesicles, cytoplasmic vesicles, and membrane-
bound vesicles, among others. Additionally, up-regulated
genes were found to be mainly enriched in six pathways
such as the calcium signaling pathway (P = 0.001) and
neuroactive ligand-receptor interactions (P = 0.001), while
the 442 down-regulated DEGs were significantly enriched
in four pathways, including pathways in cancer (P = 0.008),
calcium signaling pathway (P = 0.016), hedgehog sig-
naling pathway (P = 0.025), and MAPK signaling path-
way (P = 0.028) (Table 2). These results suggest that
perturbations in genes involved in these functions
and/or pathways are associated with bone overgrowth
following femoral fracture.
Construction of PPI network
To build the PPI network, significant protein inter-
actions were predicted; the results are displayed in
Additional file 2: Table S2. Based on these inter-
action pairs, a PPI network was constructed with
167 nodes and 233 edges (Fig. 1). Among all nodes,
three DEGs showed relatively higher degrees, includ-
ing chemokine (C–C motif ) ligand 2 (CCL2), nitric
oxide synthase 2 (NOS2), and colony-stimulating fac-
tor 2 (CSF2). Moreover, GO analysis suggested that
up-regulated CCL2 participated in the chemokine
signaling pathway, and down-regulated NOS2 involved
cancer and calcium signaling pathways. In addition,
down-regulated CSF2 was mainly enriched in the
hematopoietic cell lineage pathway.
Significant module analysis
The PPI network was processed by MCODE and a total
of 3 significant modules were obtained (Fig. 2). Module
A contained one up-regulated DEG (CCL2) and four
down-regulated DEGs (NOS2, CSF2, APOE, GAPDHS) .
Five down-regulated DEGs made up module B, including
potassium voltage-gated channel, shaker-related subfamily,
member 6 (KCNA6), potassium voltage-gated channel,
KQT-like subfamily, member 1 (KCNQ1), potassium
voltage-gated channel, Shaw-related subfamily, member 3
Table 1 Gene ontology (GO) analysis for differentially expressed
genes (DEGs)
GO-ID Description Counts P value
Up-regulated genes
GO:0009611 Response to wounding 23 3.65E−09
GO:0006952 Defense response 20 1.82E−07
GO:0006954 Inflammatory response 15 2.29E−07
GO:0010033 Response to organic
substance
29 2.52E−06
GO:0000267 Cell fraction 30 6.97E−06
GO:0042330 Taxis 9 5.29E−06





GO:0031410 Cytoplasmic vesicle 27 3.23E−04
GO:0051046 Regulation of secretion 16 2.58E−04
GO:0031982 Vesicle 28 3.44E−04
GO:0019932 Second-messenger-mediated signaling 13 2.80E−04
GO:0007187 G-protein signaling, coupled
to cyclic nucleotide second
messenger
9 3.04E−04




GO:0044421 Extracellular region part 29 6.64E−04
Table 2 Pathway enrichment for differentially expressed
genes (DEGs)
Term Count P value
Up DEGs
rno04020: Calcium signaling pathway 10 0.001065
rno04080: Neuroactive ligand-receptor interaction 12 0.001143
rno04610: Complement and coagulation cascades 6 0.003097
rno04062: Chemokine signaling pathway 7 0.034971
rno05322: Systemic lupus erythematosus 5 0.039347
rno04620: Toll-like receptor signaling pathway 5 0.039347
Down DEGs
rno05200: Pathways in cancer 15 0.008138
rno04020: Calcium signaling pathway 10 0.016627
rno04340: Hedgehog signaling pathway 5 0.025443
rno04010: MAPK signaling pathway 12 0.028372
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(KCNC3), potassium voltage-gated channel, shaker-related
subfamily, beta member 2 (KCNAB2), and potassium
voltage-gated channel, Isk-related family, member 1
(KCNE1). Moreover, module C was constituted by one up-
regulated DEGDEP domain containing seven (DEPDC7)
and five down-regulated DEGs including Rho guanine nu-
cleotide exchange factor 7 (ARHGEF7), Rho guanine nu-
cleotide exchange factor 12 (ARHGEF12), deleted in liver
cancer 1 (DLC1), kalirin, RhoGEF kinase (KALRN), and
neogenin 1 (NEO1). According to functional analysis (Table
3), DEGs in module A were mainly associated with
cGMP-mediated signaling (P = 1.47E−06) and anti-
apoptosis-related functions (P = 7.95E−06); genes in
module B were mainly related to ion transport-
associated functions (P = 1.94E−05) while DEGs in
module C were most significantly involved in the
regulation of Rho and Ras protein signal transduction
(P = 3.21E−08).
Transcription regulatory network
Based on information of transcription factors from
ENCODE and the PPI network, 387 interacting pairs
(Additional file 3: Table S3) were screened out for con-
struction of the transcription regulatory network (Fig. 3).
Analysis of functional enrichment showed that the over-
lapping nodes were significantly enriched in GO terms
such as intracellular signaling cascade, regulation of cell
proliferation, and regulation of apoptosis, among others.
Discussion
Currently, the incidence of fractures of proximal femur
have increased as industrial societies become older [23].
Femur fracture is thought to be associated with bone
overgrowth, which is a common phenomenon, particu-
larly in children. However, the underlying mechanism
remains unclear. In this study, we identified potential
genes involved in the molecular mechanism of bone
overgrowth after femoral fracture in juvenile rats by
using high-throughput bioinformatics. Based on gene ex-
pression profiles, a total of 680 DEGs were screened out,
including 238 up- and 442 down-regulated DEGs. The
up-regulated DEGs were found to be significantly
enriched in six pathways, while down-regulated DEGs
were strikingly enriched in the cancer pathway and cal-
cium signaling pathway. PPI network construction ac-
companied by module detection revealed key genes such
as CCL2, CSF2, NOS2, and DLC1 were identified to be
potentially related with femoral overgrowth.
CCL2, also known as monocyte chemoattractant
protein-1 and small inducible cytokine A2, is a chemo-
kine ligand and plays a crucial role in the recruitment
and activation of macrophages/monocytes during in-
flammation after bone injury [24]. It is well known that
activation of macrophages and monocytes can stimulate
osteoclastic bone resorption or bone formation [25, 26].
However, the recruitment of macrophages and mono-
cytes to the inflamed bone by CCL2 is regulated by
rhTNF to regulate bone formation and further improve
fracture healing, which only occurs in the fractured en-
vironment [27–29]. Additionally, the production of
CCL2 is stimulated by the receptor-activator of nuclear
factor (NF)-κB ligand, which is regarded as an essential
regulator of bone remodeling [30]. In the present study,
CCL2 was found to be up-regulated at the proximal fem-
oral growth plate of mid-shaft fracture samples com-
pared with that of no fracture samples and was
predicted to participate in cell functions; CCL2 was a
key node in the PPI network constructed of significant
interaction pairs of DEGs. Thus, CCL2 may be involved
in bone overgrowth after femora fracture via recruiting
macrophages and monocytes to fractured bone to accel-
erate bone formation.
CSF2, also known as granulocyte macrophage colony-
stimulating factor (GM-CSF), encodes a monomeric
Fig. 1 Protein-protein interaction network for differentially expressed genes (DEGs). Red circles indicate protein products of significant DEGs; blue
lines indicate interaction between different proteins
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glycoprotein which is regarded as a hemopoietic growth
factor. CSF2 is released by osteoblast lineage cells [31].
CSF2 is associated with the production, differentiation,
and function of granulocytes and macrophages in vitro
[32]. The fusion of monocytes/macrophages can form
osteoclasts, which were demonstrated to function in
degrading bone [31, 33]. Additionally, CSF2 was con-
firmed to be a target of NF-κB for inducing osteoclasto-
genesis and further promoting osteolytic bone metastasis
[34]. CSF2 has also been reported to enhance osteoclast
development which was mediated by tumor necrosis fac-
tor α [35]. In addition, CSF2 is an anti-apoptotic factor
Fig. 2 Three significant modules identified from PPI network. Red circles indicate protein products of differentially expressed genes; blue lines
indicate interaction between different proteins
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that can minimize the extent of cell death (such as
osteoclasts) in tissues surrounding the injured areas [36].
In this study, CSF2 was identified to be down-regulated.
As a result, reduced CSF2 may negatively regulate
osteoclastogenesis, resulting in partial recovery of bone
formation.
NOS2 is an isoenzyme of nitric oxide (NO) synthase
and plays an important role in producing NO, a multi-
functional signal molecule. Osteoclasts have been con-
firmed to express NOS2 and release NO in a regulated
manner [37–40]. In addition, NO is involved in the
mechanism of osteoclastic activity by releasing bone-
resorbing inflammatory cytokines [41]. Endogenously
produced NO exerts potent biphasic actions that may
significantly affect the proliferation, recruitment, differ-
entiation, and/or survival of osteoblasts and osteoclasts
[42–44]. Low levels of NO may support osteoblast bone
formation and osteoclast-mediated bone remodeling as
well as protect osteoblasts against apoptosis, while high
NO levels inhibit osteoclastogenesis and prevent bone
loss [45–47]. Additionally, NO is involved in the control
of Ca2+ dynamics and mediates Ca2+-inhibited bone
Table 3 Functional enrichment analysis for the 16 differentially expressed genes in the three significant modules
GO-ID P value corr P value x Description
Module A
19934 1.47E−06 8.16E−04 2 cGMP-mediated signaling
6916 7.95E−06 2.21E−03 3 Anti-apoptosis
48856 6.61E−05 8.68E−03 5 Anatomical structure development
43066 1.13E−04 8.68E−03 3 Negative regulation of apoptosis
43069 1.17E−04 8.68E−03 3 Negative regulation of programmed cell death
1936 1.19E−04 8.68E−03 2 Regulation of endothelial cell proliferation
51239 1.26E−04 8.68E−03 4 Regulation of multicellular organismal process
60548 1.31E−04 8.68E−03 3 Negative regulation of cell death
10646 1.49E−04 8.68E−03 4 Regulation of cell communication
32502 1.56E−04 8.68E−03 5 Developmental process
Module B
6811 2.28E−07 1.94E−05 5 Ion transport
6813 2.82E−06 1.20E−04 3 Potassium ion transport
55085 9.85E−06 2.79E−04 4 Transmembrane transport
15672 4.56E−05 9.69E−04 3 Monovalent inorganic cation transport
51899 6.14E−05 1.01E−03 2 Membrane depolarization
6810 7.76E−05 1.01E−03 5 Transport
51234 8.34E−05 1.01E−03 5 Establishment of localization
30001 1.42E−04 1.50E−03 3 Metal ion transport
51179 1.67E−04 1.58E−03 5 Localization
6812 2.86E−04 2.43E−03 3 Cation transport
Module C
35023 3.21E−08 7.84E−06 4 Regulation of Rho protein signal transduction
46578 6.27E−07 5.06E−05 4 Regulation of Ras protein signal transduction
6917 8.14E−07 5.06E−05 4 Induction of apoptosis
12502 8.29E−07 5.06E−05 4 Induction of programmed cell death
51056 1.58E−06 7.73E−05 4 Regulation of small GTPase-mediated signal transduction
8624 2.74E−06 1.12E−04 3 Induction of apoptosis by extracellular signals
43065 6.29E−06 1.59E−04 4 Positive regulation of apoptosis
43068 6.50E−06 1.59E−04 4 Positive regulation of programmed cell death
6915 6.64E−06 1.59E−04 4 Apoptosis
10942 7.15E−06 1.59E−04 4 Positive regulation of cell death
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resorption [39, 48]. Furthermore, epidermal growth fac-
tor receptor/signal transducers and activators of tran-
scription 3 can interact with the NOS2 promoter and
activate NOS2 expression [49]. In this study, NOS2 was
predicted to participate in anti-apoptosis-related func-
tions and was found to be significantly enriched in the
calcium pathway and cancer pathway. Therefore, NOS2
may participate in bone overgrowth after femora fracture
via suppressing osteoblast apoptosis through the cancer
pathway and calcium pathway. However, the regulation
of NOS2 in bone overgrowth after fracture requires fur-
ther investigation.
DLC1 encodes a Rho GTPase-activating protein that
regulates osteoclastogenesis via Rho protein signal trans-
duction [50]. Moreover, Rho GTPases have been con-
firmed to play a critical role in regulating the actin
cytoskeleton organization of osteoclasts [51]. In the
present study, DLC1 was found to be down-regulated
and enriched in the functions of regulation of Rho pro-
tein signal transduction in module C. Thus, this gene
may also be important for reducing osteoclastogenesis
and bone resorption after femur fracture.
Conclusions
The identified DEGs, particularly those in significant
gene modules, including CCL2, CSF2, NOS2, and DLC1,
may play a vital role in bone overgrowth after mid-shaft
femur fracture. Experimental studies including samples
of a larger size will be performed in the future. These
data underscore the complexity of the regulation of bone
overgrowth. Additionally, these findings form a basis for
future studies focusing on the role of these key genes in
the molecular mechanisms of bone growth disturbances
with the longer-term goal of investigating proper treat-
ment for children with fractured growing bones.
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